Norbert Weissmann Selected Research

Type 4 Cyclic Nucleotide Phosphodiesterases

3/2022	Correction to: Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.
1/2015	Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice.
5/2010	Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norbert Weissmann Research Topics

Disease

89	Pulmonary Hypertension 04/2024 - 01/2002
82	Hypoxia (Hypoxemia) 04/2024 - 01/2002
39	Vascular Remodeling 04/2024 - 05/2003
30	Pulmonary Arterial Hypertension 05/2024 - 04/2002
21	Inflammation (Inflammations) 04/2024 - 02/2007
20	Fibrosis (Cirrhosis) 04/2024 - 09/2002
17	Chronic Obstructive Pulmonary Disease (COPD) 11/2023 - 03/2010
16	Hypertrophy 01/2021 - 08/2007
15	Familial Primary Pulmonary Hypertension 05/2024 - 07/2005
14	Emphysema 11/2023 - 03/2010
11	Cardiomegaly (Heart Hypertrophy) 01/2019 - 01/2004
10	Pulmonary Fibrosis (Fibrosing Alveolitis) 03/2022 - 12/2003
9	Pneumonia (Pneumonitis) 01/2023 - 08/2002
8	Right Ventricular Hypertrophy 01/2021 - 01/2010
7	Lung Diseases (Lung Disease) 01/2022 - 11/2009
6	Idiopathic Pulmonary Fibrosis 01/2022 - 10/2010
6	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 04/2006
6	Sepsis (Septicemia) 06/2020 - 04/2006
5	Lung Injury 04/2024 - 05/2008
5	Neoplasms (Cancer) 04/2024 - 03/2004
5	Heart Failure 11/2020 - 01/2015
5	Ischemia 10/2020 - 03/2009
5	Body Weight (Weight, Body) 12/2018 - 12/2003
4	Ventricular Remodeling 07/2022 - 02/2012
4	Pulmonary Emphysema 01/2019 - 03/2010
4	Acute Lung Injury 01/2018 - 02/2007
4	Pneumococcal Pneumonia 01/2018 - 04/2014
3	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 12/2003
3	Heart Diseases (Heart Disease) 01/2022 - 08/2016
3	Neointima 01/2021 - 01/2012
3	Edema (Dropsy) 10/2020 - 05/2008
3	Atherosclerosis 10/2020 - 12/2015
3	Vascular Diseases (Vascular Disease) 03/2017 - 10/2005
3	Acidosis 01/2012 - 04/2006
3	Pulmonary Heart Disease (Cor Pulmonale) 10/2005 - 01/2004

Drug/Important Bio-Agent (IBA)

30	MonocrotalineIBA 02/2021 - 01/2004
23	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2004
17	SmokeIBA 04/2024 - 10/2011
17	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2022 - 12/2003
15	NADPH Oxidases (NAD(P)H oxidase)IBA 10/2020 - 05/2004
14	Oxygen (Dioxygen)IBA 11/2022 - 05/2003
12	Sildenafil Citrate (Viagra)FDA Link 01/2018 - 04/2002
11	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2002
11	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2020 - 09/2002
11	Iloprost (Ventavis)FDA Link 07/2008 - 04/2002
10	Semaxinib (SU5416)IBA 01/2021 - 09/2008
10	Soluble Guanylyl CyclaseIBA 01/2018 - 01/2006
10	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2015 - 11/2002
9	Bleomycin (Blenoxane)FDA LinkGeneric 04/2024 - 12/2003
9	Superoxides (Superoxide)IBA 01/2020 - 12/2003
7	CytokinesIBA 01/2022 - 03/2006
7	Messenger RNA (mRNA)IBA 10/2015 - 05/2004
7	15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic AcidIBA 02/2011 - 12/2003
6	AntioxidantsIBA 01/2023 - 04/2006
6	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 12/2022 - 01/2008
6	Protein Isoforms (Isoforms)IBA 11/2022 - 04/2006
6	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 04/2011
6	riociguatIBA 01/2019 - 03/2010
6	Phosphodiesterase 5 InhibitorsIBA 01/2018 - 01/2004
6	Small Interfering RNA (siRNA)IBA 10/2015 - 04/2011
6	Imatinib Mesylate (Gleevec)FDA Link 01/2013 - 10/2005
6	ThromboxanesIBA 02/2011 - 12/2003
6	Vasoconstrictor AgentsIBA 01/2010 - 07/2005
5	Nitric Oxide Synthase (NO Synthase)IBA 01/2022 - 04/2006
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 03/2016 - 10/2005
5	CollagenIBA 01/2015 - 12/2003
5	ProstaglandinsIBA 07/2008 - 07/2003
4	Pancreatic Elastase (Elastase)IBA 11/2023 - 12/2003
4	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 11/2009
4	Vasodilator Agents (Vasodilators)IBA 09/2021 - 04/2002
4	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2021 - 05/2011
4	Tamoxifen FDA LinkGeneric 01/2021 - 04/2012
4	Biomarkers (Surrogate Marker)IBA 06/2020 - 11/2013
4	Ion Channels (Ion Channel)IBA 01/2020 - 02/2014
4	LipidsIBA 01/2019 - 02/2007
4	Guanosine Monophosphate (5' Guanylic Acid)IBA 01/2019 - 01/2004
4	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 09/2013
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 12/2018 - 09/2008
4	TRPC6 Cation ChannelIBA 01/2017 - 12/2006
4	Platelet-Derived Growth FactorIBA 06/2012 - 04/2011
4	Epoprostenol (Prostacyclin)FDA LinkGeneric 10/2007 - 04/2002
3	RNA (Ribonucleic Acid)IBA 04/2024 - 01/2021
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 03/2022 - 05/2010
3	EnzymesIBA 01/2022 - 01/2008
3	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2021 - 08/2017
3	Tadalafil (Cialis)FDA Link 10/2020 - 10/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2018 - 07/2014
3	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2018 - 10/2004
3	EndotoxinsIBA 01/2017 - 08/2002
3	Chymases (Chymase)IBA 10/2015 - 01/2013
3	AdrenomedullinIBA 04/2014 - 03/2006
3	Becaplermin (PDGF-BB)FDA Link 01/2013 - 04/2011
3	Phosphotransferases (Kinase)IBA 06/2012 - 11/2008
3	Tyrosine (L-Tyrosine)FDA Link 04/2011 - 01/2008
3	diethylstilbestrol monophosphate (PDES)IBA 04/2011 - 01/2010
3	tolafentrineIBA 03/2011 - 04/2004
3	Phosphodiesterase InhibitorsIBA 01/2010 - 01/2005
3	Arginine (L-Arginine)FDA Link 11/2009 - 10/2006

Therapy/Procedure

24	Therapeutics 10/2021 - 04/2002
5	Lasers (Laser) 01/2021 - 09/2005